Prostate-specific antigen testing of older men

Journal of the National Cancer Institute

Volumn 91, Issue 20, 1999, Pages 1733-1737

  Carter, H Ballentine ^a,c   Landis, Patricia K ^a   Metter, E Jeffrey ^d   Fleisher, Lee A ^a   Pearson, Jay D ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ARTICLE; CANCER DIAGNOSIS; COHORT ANALYSIS; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER;

EID: 0033589322     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/91.20.1733     Document Type: Article

References (12)

1. von Eschenbach A, Ho R, Murphy GP, Cunningham M, Lins N. American Cancer Society guidelines for the early detection of prostate cancer: update, June 10, 1997. Cancer 1997;80:1805-7.
2. Albertsen PC, Hanley JA, Gleason DF, Barry MJ. Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA 1998;280:975-80.
3. Gann PH, Hennekens CH, Stampfer MJ. A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA 1995;273:289-94.
4. Shock NW, Greulich RC, Andres R, Arenberg D, Costa PT Jr, Lakatta EG, et al. Normal human aging: the Baltimore Longitudinal Study of Aging. Washington (DC): U.S. Govt Print Off; November 1984 Report No.: NIH Publ No. (NIH)84-2450.
5. Carter HB, Pearson JD, Metter EJ, Brant LJ, Chan DW, Andres R, et al. Longitudinal evaluation of prostate specific antigen levels in men with and without prostate disease. JAMA 1992;267:2215-20.
6. Schroder FH, Hermanek P, Denis L, Fair WR, Gospodarowicz MK, Pavone-Macaluso M. The TNM classification of prostate cancer. Prostate Suppl 1992;4:129-38.
7. Gleason DF. Classification of prostatic carcinomas. Cancer Chemother Rep 1966;50:125-8.
8. International Classification of Disease, 9th revision - clinical modification (ICD.9.CM). 4th ed. New York (NY): McGraw-Hill; 1995.
9. th ed. In: Hanna A, editor. Bethesda (MD): National Institutes of Health, National Cancer Institute: 1996.
10. 1996 HCFA statistics. Health Care Financing Administration, Bureau of Data Management and Strategy; HCFA Publ No. 03394, September 1996.
11. Jacobsen SJ, Klee GG, Lilja H, Wright GL Jr, Oesterling JE. Stability of serum prostate-specific antigen determination across laboratory, assay, and storage time. Urology 1995;45:447-53.
12. Pound CR, Partin AW, Epstein JI, Walsh PC. Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control. Urol Clin North Am 1997;24:395-406.